Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology

Nano-5-aminolevulic acid (NanoALA)-mediated photodynamic therapy (PDT), an oil-in-water polymeric nanoemulsion of ALA, was evaluated in a murine model of breast cancer. Analysis of ALA-derived protoporphyrin IX production and acute toxicity test, biocompatibility and treatment efficacy, and long-ter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanomedicine (London, England) England), 2020-04, Vol.15 (10), p.1019-1036
Hauptverfasser: de Andrade, Laise R, Tedesco, Antonio C, Primo, Fernando L, Farias, Gabriel R, da Silva, Jaqueline R, Longo, João Pf, de Almeida, Marcos C, de Souza, Paulo En, de Azevedo, Ricardo B, Pinheiro, Willie O, Lacava, Zulmira Gm
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1036
container_issue 10
container_start_page 1019
container_title Nanomedicine (London, England)
container_volume 15
creator de Andrade, Laise R
Tedesco, Antonio C
Primo, Fernando L
Farias, Gabriel R
da Silva, Jaqueline R
Longo, João Pf
de Almeida, Marcos C
de Souza, Paulo En
de Azevedo, Ricardo B
Pinheiro, Willie O
Lacava, Zulmira Gm
description Nano-5-aminolevulic acid (NanoALA)-mediated photodynamic therapy (PDT), an oil-in-water polymeric nanoemulsion of ALA, was evaluated in a murine model of breast cancer. Analysis of ALA-derived protoporphyrin IX production and acute toxicity test, biocompatibility and treatment efficacy, and long-term effect of NanoALA-PDT on tumor progression were performed. The nanoformulation favored the prodrug uptake by tumor cells in a shorter time (1.5 h). As a result, the adverse effects were negligible and the response rates for primary mammary tumor control were significantly improved. Tumor progression was slower after NanoALA-PDT treatment, providing longer survival. NanoALA is a good proactive drug candidate for PDT against cancer potentially applied as adjuvant/neoadjuvant intervention strategy for breast cancer.
doi_str_mv 10.2217/nnm-2019-0458
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2387646680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2407348221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-710a375c72aa579a896869737ab33b641df2dc7e254a019d9a208bea41f79c353</originalsourceid><addsrcrecordid>eNp1kUtv1DAURiNERUthyRZZYsMm1K_4wW5UFVppRDdlbTnODZMqsYPtjJR_X6dTWCCx8kPnfrK_U1UfCP5CKZFX3k81xUTXmDfqVXVBJFe10IK9ft6zulFKn1dvU3rEuFGU4DfVOaNUcCnERXV8WKYQkYNxRB3YfECDRyHmQ8hhHhxqI9iUkbPeQURT6GBE7Yp-WB92-91XZJEPx3I3Q0wzuDwcAQWP5m2-W72dSkY-QLTz-pzsXRjDr_VdddbbMcH7l_Wy-vnt5uH6tt7ff7-73u1rxyTJtSTYMtk4Sa1tpLZKCyW0ZNK2jLWCk66nnZNAG25LB522FKsWLCe91I417LL6fMqdY_i9QMpmGtL2WeshLMlQpqTgQihc0E__oI9hib68zlCOJeOq9F2o-kS5GFKK0Js5DpONqyHYbEJMEWI2IWYTUviPL6lLO0H3l_5joAD6BPRLXiIkN0Cp2pxOZWJwg4f_hD8BxT-aLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2407348221</pqid></control><display><type>article</type><title>Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology</title><source>PubMed Central</source><creator>de Andrade, Laise R ; Tedesco, Antonio C ; Primo, Fernando L ; Farias, Gabriel R ; da Silva, Jaqueline R ; Longo, João Pf ; de Almeida, Marcos C ; de Souza, Paulo En ; de Azevedo, Ricardo B ; Pinheiro, Willie O ; Lacava, Zulmira Gm</creator><creatorcontrib>de Andrade, Laise R ; Tedesco, Antonio C ; Primo, Fernando L ; Farias, Gabriel R ; da Silva, Jaqueline R ; Longo, João Pf ; de Almeida, Marcos C ; de Souza, Paulo En ; de Azevedo, Ricardo B ; Pinheiro, Willie O ; Lacava, Zulmira Gm</creatorcontrib><description>Nano-5-aminolevulic acid (NanoALA)-mediated photodynamic therapy (PDT), an oil-in-water polymeric nanoemulsion of ALA, was evaluated in a murine model of breast cancer. Analysis of ALA-derived protoporphyrin IX production and acute toxicity test, biocompatibility and treatment efficacy, and long-term effect of NanoALA-PDT on tumor progression were performed. The nanoformulation favored the prodrug uptake by tumor cells in a shorter time (1.5 h). As a result, the adverse effects were negligible and the response rates for primary mammary tumor control were significantly improved. Tumor progression was slower after NanoALA-PDT treatment, providing longer survival. NanoALA is a good proactive drug candidate for PDT against cancer potentially applied as adjuvant/neoadjuvant intervention strategy for breast cancer.</description><identifier>ISSN: 1743-5889</identifier><identifier>EISSN: 1748-6963</identifier><identifier>DOI: 10.2217/nnm-2019-0458</identifier><identifier>PMID: 32264766</identifier><language>eng</language><publisher>England: Future Medicine Ltd</publisher><subject>4T1 cells ; 5-aminolevulinic acid ; Apoptosis ; Breast cancer ; Cancer therapies ; Cell death ; Metastasis ; Nanoemulsions ; Photodynamic therapy ; Physiology ; polymeric nanoemulsion ; Prostate ; Skin ; Software</subject><ispartof>Nanomedicine (London, England), 2020-04, Vol.15 (10), p.1019-1036</ispartof><rights>2020 Future Medicine Ltd</rights><rights>Copyright Future Medicine Ltd Apr 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-710a375c72aa579a896869737ab33b641df2dc7e254a019d9a208bea41f79c353</citedby><cites>FETCH-LOGICAL-c371t-710a375c72aa579a896869737ab33b641df2dc7e254a019d9a208bea41f79c353</cites><orcidid>0000-0003-2390-3539 ; 0000-0002-6017-7057</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32264766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Andrade, Laise R</creatorcontrib><creatorcontrib>Tedesco, Antonio C</creatorcontrib><creatorcontrib>Primo, Fernando L</creatorcontrib><creatorcontrib>Farias, Gabriel R</creatorcontrib><creatorcontrib>da Silva, Jaqueline R</creatorcontrib><creatorcontrib>Longo, João Pf</creatorcontrib><creatorcontrib>de Almeida, Marcos C</creatorcontrib><creatorcontrib>de Souza, Paulo En</creatorcontrib><creatorcontrib>de Azevedo, Ricardo B</creatorcontrib><creatorcontrib>Pinheiro, Willie O</creatorcontrib><creatorcontrib>Lacava, Zulmira Gm</creatorcontrib><title>Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology</title><title>Nanomedicine (London, England)</title><addtitle>Nanomedicine (Lond)</addtitle><description>Nano-5-aminolevulic acid (NanoALA)-mediated photodynamic therapy (PDT), an oil-in-water polymeric nanoemulsion of ALA, was evaluated in a murine model of breast cancer. Analysis of ALA-derived protoporphyrin IX production and acute toxicity test, biocompatibility and treatment efficacy, and long-term effect of NanoALA-PDT on tumor progression were performed. The nanoformulation favored the prodrug uptake by tumor cells in a shorter time (1.5 h). As a result, the adverse effects were negligible and the response rates for primary mammary tumor control were significantly improved. Tumor progression was slower after NanoALA-PDT treatment, providing longer survival. NanoALA is a good proactive drug candidate for PDT against cancer potentially applied as adjuvant/neoadjuvant intervention strategy for breast cancer.</description><subject>4T1 cells</subject><subject>5-aminolevulinic acid</subject><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Cell death</subject><subject>Metastasis</subject><subject>Nanoemulsions</subject><subject>Photodynamic therapy</subject><subject>Physiology</subject><subject>polymeric nanoemulsion</subject><subject>Prostate</subject><subject>Skin</subject><subject>Software</subject><issn>1743-5889</issn><issn>1748-6963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kUtv1DAURiNERUthyRZZYsMm1K_4wW5UFVppRDdlbTnODZMqsYPtjJR_X6dTWCCx8kPnfrK_U1UfCP5CKZFX3k81xUTXmDfqVXVBJFe10IK9ft6zulFKn1dvU3rEuFGU4DfVOaNUcCnERXV8WKYQkYNxRB3YfECDRyHmQ8hhHhxqI9iUkbPeQURT6GBE7Yp-WB92-91XZJEPx3I3Q0wzuDwcAQWP5m2-W72dSkY-QLTz-pzsXRjDr_VdddbbMcH7l_Wy-vnt5uH6tt7ff7-73u1rxyTJtSTYMtk4Sa1tpLZKCyW0ZNK2jLWCk66nnZNAG25LB522FKsWLCe91I417LL6fMqdY_i9QMpmGtL2WeshLMlQpqTgQihc0E__oI9hib68zlCOJeOq9F2o-kS5GFKK0Js5DpONqyHYbEJMEWI2IWYTUviPL6lLO0H3l_5joAD6BPRLXiIkN0Cp2pxOZWJwg4f_hD8BxT-aLw</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>de Andrade, Laise R</creator><creator>Tedesco, Antonio C</creator><creator>Primo, Fernando L</creator><creator>Farias, Gabriel R</creator><creator>da Silva, Jaqueline R</creator><creator>Longo, João Pf</creator><creator>de Almeida, Marcos C</creator><creator>de Souza, Paulo En</creator><creator>de Azevedo, Ricardo B</creator><creator>Pinheiro, Willie O</creator><creator>Lacava, Zulmira Gm</creator><general>Future Medicine Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2390-3539</orcidid><orcidid>https://orcid.org/0000-0002-6017-7057</orcidid></search><sort><creationdate>20200401</creationdate><title>Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology</title><author>de Andrade, Laise R ; Tedesco, Antonio C ; Primo, Fernando L ; Farias, Gabriel R ; da Silva, Jaqueline R ; Longo, João Pf ; de Almeida, Marcos C ; de Souza, Paulo En ; de Azevedo, Ricardo B ; Pinheiro, Willie O ; Lacava, Zulmira Gm</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-710a375c72aa579a896869737ab33b641df2dc7e254a019d9a208bea41f79c353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>4T1 cells</topic><topic>5-aminolevulinic acid</topic><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Cell death</topic><topic>Metastasis</topic><topic>Nanoemulsions</topic><topic>Photodynamic therapy</topic><topic>Physiology</topic><topic>polymeric nanoemulsion</topic><topic>Prostate</topic><topic>Skin</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Andrade, Laise R</creatorcontrib><creatorcontrib>Tedesco, Antonio C</creatorcontrib><creatorcontrib>Primo, Fernando L</creatorcontrib><creatorcontrib>Farias, Gabriel R</creatorcontrib><creatorcontrib>da Silva, Jaqueline R</creatorcontrib><creatorcontrib>Longo, João Pf</creatorcontrib><creatorcontrib>de Almeida, Marcos C</creatorcontrib><creatorcontrib>de Souza, Paulo En</creatorcontrib><creatorcontrib>de Azevedo, Ricardo B</creatorcontrib><creatorcontrib>Pinheiro, Willie O</creatorcontrib><creatorcontrib>Lacava, Zulmira Gm</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>UK &amp; Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nanomedicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Andrade, Laise R</au><au>Tedesco, Antonio C</au><au>Primo, Fernando L</au><au>Farias, Gabriel R</au><au>da Silva, Jaqueline R</au><au>Longo, João Pf</au><au>de Almeida, Marcos C</au><au>de Souza, Paulo En</au><au>de Azevedo, Ricardo B</au><au>Pinheiro, Willie O</au><au>Lacava, Zulmira Gm</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology</atitle><jtitle>Nanomedicine (London, England)</jtitle><addtitle>Nanomedicine (Lond)</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>15</volume><issue>10</issue><spage>1019</spage><epage>1036</epage><pages>1019-1036</pages><issn>1743-5889</issn><eissn>1748-6963</eissn><abstract>Nano-5-aminolevulic acid (NanoALA)-mediated photodynamic therapy (PDT), an oil-in-water polymeric nanoemulsion of ALA, was evaluated in a murine model of breast cancer. Analysis of ALA-derived protoporphyrin IX production and acute toxicity test, biocompatibility and treatment efficacy, and long-term effect of NanoALA-PDT on tumor progression were performed. The nanoformulation favored the prodrug uptake by tumor cells in a shorter time (1.5 h). As a result, the adverse effects were negligible and the response rates for primary mammary tumor control were significantly improved. Tumor progression was slower after NanoALA-PDT treatment, providing longer survival. NanoALA is a good proactive drug candidate for PDT against cancer potentially applied as adjuvant/neoadjuvant intervention strategy for breast cancer.</abstract><cop>England</cop><pub>Future Medicine Ltd</pub><pmid>32264766</pmid><doi>10.2217/nnm-2019-0458</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0003-2390-3539</orcidid><orcidid>https://orcid.org/0000-0002-6017-7057</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1743-5889
ispartof Nanomedicine (London, England), 2020-04, Vol.15 (10), p.1019-1036
issn 1743-5889
1748-6963
language eng
recordid cdi_proquest_miscellaneous_2387646680
source PubMed Central
subjects 4T1 cells
5-aminolevulinic acid
Apoptosis
Breast cancer
Cancer therapies
Cell death
Metastasis
Nanoemulsions
Photodynamic therapy
Physiology
polymeric nanoemulsion
Prostate
Skin
Software
title Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A46%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20cell%20death%20in%20orthotopic%20breast%20cancer%20model%20by%20NanoALA:%20a%20novel%20perspective%20on%20photodynamic%20therapy%20in%20oncology&rft.jtitle=Nanomedicine%20(London,%20England)&rft.au=de%20Andrade,%20Laise%20R&rft.date=2020-04-01&rft.volume=15&rft.issue=10&rft.spage=1019&rft.epage=1036&rft.pages=1019-1036&rft.issn=1743-5889&rft.eissn=1748-6963&rft_id=info:doi/10.2217/nnm-2019-0458&rft_dat=%3Cproquest_cross%3E2407348221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2407348221&rft_id=info:pmid/32264766&rfr_iscdi=true